A detailed history of Israel Englander (Millennium Management LLC) transactions in Artivion, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 486,123 shares of AORT stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
486,123
Previous 503,874 3.52%
Holding current value
$12.2 Million
Previous $10.7 Million 16.96%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.62 - $25.65 $348,274 - $455,313
-17,751 Reduced 3.52%
486,123 $12.5 Million
Q1 2024

May 15, 2024

BUY
$16.7 - $21.63 $5.51 Million - $7.14 Million
329,986 Added 189.77%
503,874 $10.7 Million
Q4 2023

Feb 14, 2024

SELL
$12.33 - $18.83 $387,753 - $592,165
-31,448 Reduced 15.32%
173,888 $3.11 Million
Q2 2023

Aug 14, 2023

SELL
$12.78 - $17.23 $2.11 Million - $2.85 Million
-165,391 Reduced 44.61%
205,336 $3.53 Million
Q1 2023

May 15, 2023

SELL
$11.74 - $14.12 $2.94 Million - $3.54 Million
-250,755 Reduced 40.35%
370,727 $4.86 Million
Q4 2022

Feb 14, 2023

SELL
$10.01 - $13.9 $873,172 - $1.21 Million
-87,230 Reduced 12.31%
621,482 $7.53 Million
Q3 2022

Nov 14, 2022

BUY
$13.31 - $23.25 $8.36 Million - $14.6 Million
628,174 Added 779.97%
708,712 $9.81 Million
Q2 2022

Aug 15, 2022

SELL
$15.73 - $22.91 $2.55 Million - $3.71 Million
-161,930 Reduced 66.78%
80,538 $1.52 Million
Q1 2022

May 16, 2022

SELL
$16.95 - $21.74 $3.34 Million - $4.28 Million
-196,909 Reduced 44.82%
242,468 $5.18 Million
Q4 2021

Feb 14, 2022

BUY
$17.19 - $22.84 $227,595 - $302,401
13,240 Added 3.11%
439,377 $8.94 Million
Q3 2021

Nov 15, 2021

BUY
$22.29 - $28.7 $2.89 Million - $3.71 Million
129,438 Added 43.63%
426,137 $9.5 Million
Q2 2021

Aug 16, 2021

BUY
$22.32 - $32.07 $325,916 - $468,286
14,602 Added 5.18%
296,699 $8.43 Million
Q1 2021

May 17, 2021

BUY
$22.07 - $26.31 $2.2 Million - $2.62 Million
99,564 Added 54.55%
282,097 $6.37 Million
Q4 2020

Feb 16, 2021

SELL
$16.76 - $23.74 $1.17 Million - $1.66 Million
-69,865 Reduced 27.68%
182,533 $4.31 Million
Q3 2020

Nov 16, 2020

BUY
$16.35 - $21.4 $2.81 Million - $3.68 Million
172,156 Added 214.55%
252,398 $4.66 Million
Q2 2020

Aug 14, 2020

BUY
$16.34 - $25.24 $1.04 Million - $1.6 Million
63,552 Added 380.78%
80,242 $1.54 Million
Q1 2020

May 14, 2020

BUY
$14.66 - $30.57 $244,675 - $510,213
16,690 New
16,690 $282,000
Q4 2019

Feb 14, 2020

SELL
$22.45 - $27.09 $373,410 - $450,587
-16,633 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$25.98 - $30.8 $9.31 Million - $11 Million
-358,287 Reduced 95.56%
16,633 $451,000
Q2 2019

Aug 15, 2019

BUY
$27.55 - $32.39 $2.32 Million - $2.73 Million
84,205 Added 28.96%
374,920 $11.2 Million
Q2 2019

Aug 14, 2019

BUY
$27.55 - $32.39 $5.97 Million - $7.02 Million
216,706 Added 292.81%
290,715 $3.14 Million
Q1 2019

May 14, 2019

BUY
$25.85 - $30.47 $1.73 Million - $2.03 Million
66,779 Added 923.64%
74,009 $2.16 Million
Q4 2018

Feb 14, 2019

BUY
$25.76 - $34.03 $186,244 - $246,036
7,230 New
7,230 $205,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.01B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.